STOCK TITAN

Aurora Cannabis to Host Third Quarter Fiscal Year 2021 Investor Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Aurora Cannabis Inc. (ACB) will hold a conference call on May 13, 2021, at 5:00 p.m. Eastern Time to discuss its third-quarter fiscal year 2021 results. The financial results will be released after market close on the same day. CEO Miguel Martin and CFO Glen Ibbott will lead the call, which will include a question and answer session. Aurora is recognized as a global leader in the cannabis industry, providing innovative products across medical and consumer markets.

Positive
  • None.
Negative
  • None.

NYSE | TSX: ACB

EDMONTON, AB, April 30, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its third quarter fiscal year 2021 on Thursday, May 13, 2021 at 5:00 p.m. Eastern Time. Miguel Martin, Chief Executive Officer, and Glen Ibbott, Chief Financial Officer, will host the call and a question and answer period. The Company will report its financial results for the third quarter after the close of markets on Thursday, May 13, 2021.

Conference Call Details

DATE:


Thursday, May 13, 2021

TIME:


5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time

WEBCAST:


http://public.viavid.com/index.php?id=144524

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com.

Aurora's common shares trade on the TSX and NYSE under the symbol "ACB", and is a constituent of the S&P/TSX Composite Index.

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management's experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora's business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 24, 2020 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-to-host-third-quarter-fiscal-year-2021-investor-conference-call-301280872.html

SOURCE Aurora Cannabis Inc.

FAQ

What date is the Aurora Cannabis Q3 2021 results conference call?

The conference call is scheduled for May 13, 2021.

What time will the Aurora Cannabis conference call start?

The call will begin at 5:00 p.m. Eastern Time.

Who will host the Aurora Cannabis conference call?

CEO Miguel Martin and CFO Glen Ibbott will host the call.

When will Aurora Cannabis release its Q3 2021 financial results?

The financial results will be reported after the market closes on May 13, 2021.

Where can I find the webcast for the Aurora Cannabis conference call?

The webcast can be accessed at http://public.viavid.com/index.php?id=144524.

Aurora Cannabis Inc. Common Shares

NASDAQ:ACB

ACB Rankings

ACB Latest News

ACB Stock Data

225.00M
54.75M
13.04%
7.99%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Edmonton